CD34 and neoplasm: Although longer interval from drug administration to initiation of apheresis, higher risk of neutropenic fever, and increase require of hospitalization associated with chemotherapy-based mobilization are widely reported, patients still could greatly benefit from decreased tumor cells burden and high CD34+ cells yield [18].